中文别名: |
2-(4-吗啉基)-16-(1-吡咯基)-雄甾-3,17-二醇;雄甾-3,17-二醇, 2-(4-吗啉基)-16-(1-吡咯烷基)-, (2B,3A,5A,16B,17B)- (9CI);罗库溴铵中间体LK-7;(2b,3a,5a,16b,17b)-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二醇;(2b,3a,5a,16b,17b)-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二;氘代苝;罗库溴铵EP杂质G;罗库溴铵杂质II;罗库溴铵中间体7;罗库溴铵中间体LK-7粉;(2Β,2Α,16Β,17Β))-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二醇;(2Β,3Α,5Α,16Β,17Β)-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二醇;2??(4-吗啉基)-16-(1-吡咯基)-雄甾-3,17-二醇;罗库溴铵中间体七;雄甾-3,17-二醇,2-(4吗啉基)-16-(1-吡咯烷基);罗库溴铵中间体C;罗库溴胺EP杂质G;雄甾-3,17-二醇,2-(4吗啉基)-16-(1-吡咯烷基)-;2Β-(4-吗啉基)-16Β-(1-吡咯烷基)-5Α-雄甾烷-3Α,17Β-二醇;3Α,17Β-(二羟基)-2Β-(吗啉-1-基)-16-(吡咯烷-1-基)-5Α-雄甾烷;(2b,3a,5a,16b,17b)-2-(4-吗啉基)-16-(1-吡咯烷基)雄烷-3,17-二醇;(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇 |
英文别名: |
(2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol;Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl);(2b,3a,5a,16b,17b)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol(9CI);2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)-5-ANDROSTANE-3,17-DIOL;3,17-DIHYDROXY-2-(4-MORPHOLINYL)-16-(1-PYRROLINYL)-ANDROSTANE;3,17-dihydroxy-2-(4-morpholinyl)-16-(1-pyrroliny)-androstane;2,3-Epoxy-1H-cyclopenta[a]phenanthrene,anddrostan-17-ol deriv;,3a,5a,16ß,17ß)-2-(4-Morpholiny)-16-(1-Pyrrolidinyl)Androstane-3,17-Diol;(2β,3α,5α,16β,17β)-2;(2β,3α,5α,16β,17β)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol;Androstane-3,17-diol, 2-(4- morpholinyl)-16-(1-pyrrolidinyl)-, (2β,3α,5α,16β,17β)-;Rocuronium Bromide Intermediate VII;Rocuronium Intermediate;(2b,3a,5a,16b,17b)-2-(4-Morphlinyl)-16-(1-Pyrrolidinyl)androstene-3,17-diol;(2Beta,3Alpha,5Alpha,16Beta,17Beta)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol;2,3-Epoxy-1H-cyclopenta[a]phenanthrene,anddrostan-17-ol;3,17-dihydroxy-2-(4-morpholinyl);The intermediate of LK-7;RocuroniuM interMediate C;Rocuronium intermediate LK-7;RocuroniuM broMide EP iMpurity G;Ammonium bromide intermediate LK-7;Rocuronium bromide intermediate LK-7;CS-0198874;A804248;(2;A)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol;(2beta,3alpha,5alpha,16beta,17beta)-2(4-morpholinyl)-16-(1-pyrro lidinyl)-androstane-3,17-diol;2.BETA.-(MORPHOLIN-4-YL)-16.BETA.-(PYRROLIDIN-1-YL)-5.ALPHA.-ANDROSTAN-3.ALPHA.,17.BETA.-DIOL;Rocuronium Bromide EP Impurity G;2-(MORPHOLIN-4-YL)-16-(PYRROLIDIN-1-YL)-5-ANDROSTANE-3,17-DIOL;(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-dimethyl-2-morpholin-4-yl-16-pyrrolidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol;2beta-(4-morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstan-3alpha,17beta-diol;(2b,3a,5a,16b,17b)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol;A,5;ROCURONIUM BROMIDE IMPURITY G [EP IMPURITY];A,16;ANDROSTANE-3,17-DIOL, 2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)-, (2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-;YKHDYPFPUAWBIW-QJRNWJQSSA-N;(2beta,3alpha,5alpha,16beta,17beta)-2-(4-morpholinyl)-16-(1pyrrolidinyl)-androstane-3,17-diol;2beta-(4-Morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstane-3alpha,17beta-diol;A,3;(2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol(9CI);Q-101012;119302-20-4;SCHEMBL3454056;AKOS015895261;A,17;(2beta,3alpha,5alpha,16beta,17beta)-2(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol;DTXSID001166831;Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, (2beta,3alpha,5alpha,16beta,17beta)-;RocuroniuM InterMediate;RocuroniuM BroMide InterMediate VII |